Internal Medicine, Endocrinology, Diabetes, & Metabolism · Deland, FL
NPI
1407851801
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
141 Victoria Commons Blvd
Deland, FL, 32724
Phone (386) 427-4544
Groups this clinician bills Medicare through
Medicare paid, 2024
$364K
4,887 services
Medicare patients, 2024
1,407
Average age 74
Drug cost, 2024
$4.9M
7,310 prescriptions
Company payments, 2025
$56K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee N Metchick was code 99214 (office e&m - established), 1,282 times for 852 patients. In total Lee N Metchick billed 4,887 services in 19 codes, and Medicare paid $364K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,282 | 852 | $87.34 | $112K |
| 99215 Office E&M - Established | Office | 1,101 | 609 | $126.77 | $140K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 945 | 475 | $12.49 | $12K |
| 76536 Ultrasound - Nonspecific | Office | 563 | 534 | $71.17 | $40K |
| 95251 Test - Miscellaneous | Office | 261 | 126 | $25.71 | $6,712 |
| 99204 Office E&M - New | Office | 231 | 231 | $117.41 | $27K |
| 88172 Surgical Pathology Examination | Office | 182 | 75 | $41.70 | $7,590 |
| 83037 Blood Count | Office | 109 | 95 | $9.35 | $1,019 |
| 10005 Other Organ Systems | Office | 82 | 76 | $99.18 | $8,133 |
| 99205 Office E&M - New | Office | 49 | 49 | $156.92 | $7,689 |
| 82962 Clinical Chemistry | Office | 28 | 27 | $3.10 | $86.87 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 14 | 11 | $25.26 | $354 |
| 10006 Other Organ Systems | Office | 12 | 11 | $46.97 | $564 |
By year: 2022 $271K for 3,926 services; 2023 $316K for 3,580 services; 2024 $364K for 4,887 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88172 Surgical Pathology Examination | 182 | 75 | $41.70 | $7,590 |
| 83037 Blood Count | 109 | 95 | $9.35 | $1,019 |
| 82962 Clinical Chemistry | 28 | 27 | $3.10 | $86.87 |
Medicare prescription drug claims, 2024
In 2024, the drug Lee N Metchick prescribed most often to Medicare patients was Levothyroxine Sodium, with 885 prescriptions and refills. In total Lee N Metchick wrote 7,310 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 885 | 2,521 | 350 | $9,169 |
| Mounjaro Tirzepatide | 421 | 586 | 119 | $620K |
| Ozempic Semaglutide | 408 | 781 | 139 | $741K |
| Metformin Hcl Generic | 391 | 1,137 | 162 | $3,143 |
| Synthroid Levothyroxine Sodium | 316 | 787 | 121 | $28K |
| Jardiance Empagliflozin | 292 | 662 | 104 | $384K |
| Pioglitazone Hcl Generic | 245 | 687 | 99 | $3,414 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 210 | 607 | 93 | $19K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 205 | 504 | 79 | $354K |
| Metformin Hcl Er Metformin Hcl | 182 | 529 | 74 | $2,204 |
| Tresiba Flextouch U-200 Insulin Degludec | 182 | 463 | 68 | $244K |
| Rosuvastatin Calcium Generic | 176 | 521 | 67 | $2,494 |
| Atorvastatin Calcium Generic | 176 | 531 | 60 | $2,024 |
| Lisinopril Generic | 161 | 465 | 52 | $1,095 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 154 | 344 | 57 | $207K |
Brand drugs: 3,804 claims; generic drugs: 3,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee N Metchick $56K ($56K in general payments such as food, travel and fees) from 27 companies. The largest payer was Lilly USA, LLC with $54K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.